ArticleACS materials letters2025
Engineering the Electronic Structure and Optoelectronic Properties of Chiral Metal Halides through Cation Design.
Article in ACS materials letters, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The tunability of hybrid organic-inorganic metal halides through targeted chemical design is one of their most attractive features, enabling fine control over physical properties for optoelectronic applications. In chiral systems, where chirality is introduced via organic amines, this tunability is often limited by the scarcity of suitable chiral cations. In this study, we report a family of 1D lead- and tin-based chiral hybrid halides incorporating a tailor-made cation bearing both amino and hydroxyl functional groups. This chiral ligand enables the synthesis of enantiopure (
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.